Purchase Order HHSF223201610329P
- Not listed
- This is a $210,267.91 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Sartorius Stedim North America Inc., a subsidiary of the German company Sartorius Aktiengesellschaft. The contract is for the delivery of off-line gas analyzers, on-line and integral nutrient analyzers, bioreactor probes, and accessories for a Sartorius BIOSTAT bioreactor system. This award does not have a set-aside designation. Sartorius Stedim North America...
- The Department of Health and Human Services Food and Drug Administration has awarded a firm fixed price purchase order to Sartorius Stedim North America Inc., a division of the German company Sartorius Aktiengesellschaft, to provide an AMBR15 analysis module equipped with BioPAT Spectro hardware and flow cell. The contract has a potential value of $90,507.50 and a completion date of November 17, 2023. No set-aside designation was used for this award. Sartorius Stedim North America Inc. is a...
- The National Center for Advancing Translational Sciences, a civilian agency within the Department of Health and Human Services, awarded a firm-fixed-price purchase order contract worth $36,585.00 to Sartorius Stedim North America Inc., a division of the German company Sartorius Aktiengesellschaft. The contract, which does not have a set-aside designation, has a period of performance through December 4, 2024. Sartorius Stedim North America Inc. is a leading provider of laboratory equipment,...
- This is a $21,343.18 firm fixed-price purchase order contract awarded by the Plains Area agency to Sartorius Stedim North America Inc., a foreign-owned for-profit subsidiary of the German company Sartorius Aktiengesellschaft. The contract is for the provision of a SARTORIUS BIOSTAT A BIOREACTOR. No set-aside was used for this award. Sartorius Stedim North America Inc. is a leading supplier of advanced laboratory equipment, consumables, and services to various federal agencies, including the...
- The Food and Drug Administration awarded a $86.8K firm fixed-price purchase order to Sartorius Stedim North America Inc. for operational parts and software updates to Biostat B-DCU II bioprocess control units equipped with BioPat analytics systems. The contract, awarded on September 17, 2019, with a completion date of January 30, 2020, represents a non-set-aside procurement for specialized biopharmaceutical manufacturing support equipment. Sartorius Stedim North America Inc., a subsidiary of...
- Sartorius Stedim North America, Inc. was awarded a $126,870 purchase order by the Department of Health and Human Services' Food and Drug Administration to provide bioreactor parts and components. As the prime contractor, Sartorius Stedim North America will deliver the requested biomanufacturing equipment components from its Bohemia, New York facility in support of the FDA's regulatory and research programs. The firm fixed price contract runs from August 2023 through September 2024. No set...
- This firm fixed-price purchase order was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency within the U.S. Department of Health and Human Services, to Sartorius Stedim North America Inc., a foreign-owned, for-profit organization specializing in advanced laboratory equipment and services. The $77,605.00 contract, awarded on September 27, 2010, is for the delivery of a BDCU 11 TWIN system by the ultimate completion date of March 30, 2011. The...
- This $215,273 firm-fixed-price purchase order contract was awarded by the Plains Area, a civilian agency, to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions for the biopharmaceutical and life sciences industries. The contract is for the installation and training of large-scale bioreactors, which are essential for efficiently producing biologics in quantities suitable for commercial scale-up operations while maintaining quality. The contract...
- The Department of Health and Human Services Food and Drug Administration awarded a $227,968.50 firm fixed price purchase order for service and maintenance on a Sartorius Stedim North America Inc. Ambr 15 bioreactor system. The contract has a completion date of June 30, 2023 and was awarded on a competitive basis with no set-aside designation. Sartorius Stedim North America Inc. is the prime contractor, a division of the German company Sartorius Aktiengesellschaft, and has fulfilled over $2...
- The Department of Health and Human Services Food and Drug Administration has awarded a firm-fixed-price purchase order valued at $211,279.00 to Sartorius Stedim North America Inc., a division of the German company Sartorius Aktiengesellschaft. The contract is for the delivery of the AMBR250 4-WAY MODULAR SYSTEM, which is a bioreactor product used to support the biopharmaceutical manufacturing process. Sartorius Stedim North America Inc. is a leading provider of laboratory equipment, consumables,...
This is a firm fixed-price purchase order awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, to Sartorius Stedim North America Inc. for the provision of laboratory equipment. The contract has a ceiling value of $173,248.00 and an ultimate completion date of September 29, 2018. The contract was awarded on August 31, 2016 and was not set aside for a specific type of business. Sartorius Stedim North America Inc. is a foreign-owned, for-profit organization that has established itself as a supplier of laboratory equipment, consumables, and services to various federal agencies, including the Department of Health and Human Services, the Environmental Protection Agency, and the Department of Agriculture. The company has provided bioreactors, filtration systems, analytical instruments, software platforms, and other specialized laboratory equipment to support scientific research and development activities across the government.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Preventative Maintenance Service for the TAP Biosystems Ambr Workstation 15C | FDA-SOL-1165862 | Department of Health and Human Services Food and Drug Administration | Award Notice 1/1 | 6/23/16, 9:52 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Exercise an Option | $42.4k | 3/10/17 | |
| Not listed | Not listed | $42.4k | 8/31/16 |